
Anondita Medicare Secures First Export Order Worth ₹43.14 Crore from South Africa
Anondita Medicare Limited, a leading manufacturer of condoms and sexual wellness products operating under its flagship brand 'COBRA,' has announced the securing of its first export purchase order. The significant order, valued at approximately ₹43.14 Crore, originates from the South African Government's condom procurement program.The company, which is listed on the NSE SME board under the ticker ANONDITA, received the order from Supra Healthcare Johannesburg (Pty) Ltd. in South Africa. This purchase order confirms the company's entry into the South African tender framework for the supply of male condoms.
The details of the export order are as follows:
| Detail | Description |
|---|---|
| Value | Approximately ₹43.14 Crore |
| Buyer | Supra Healthcare Johannesburg (Pty) Ltd., South Africa |
| Product | Male Condoms |
| Volume | Equivalent to 50 containers (40-foot containers) |
| Execution Deadline | Expected by September 30, 2026 |
The successful securing of this deal marks a major milestone for Anondita Medicare, validating its manufacturing excellence and global quality standards.
Anupam Ghosh, Managing Director of Anondita Medicare Limited, commented on the development, stating that the order for male condoms equivalent to 50 containers strengthens the company's export business and enhances its presence in international institutional markets.
Anondita Medicare Limited is an Indian manufacturer specializing in condoms and sexual wellness products. The company operates its own manufacturing facility and adheres to a quality-driven, compliant production model. With strong industry expertise, the company has focused on automation-led capacity enhancement and developing innovative patented female condom products, positioning it for growth across both domestic and international markets.
ANONDITA Stock Price Movement
On Friday, Anondita Medicare Limited shares gained 5.30% on the close, settling at ₹1061.95. The equity finished the session on 25,200 shares, following a solid performance that outperformed its previous day's close.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.